BRPI1007413A2 - Composição compreendendo ácido caftárico e/ou seus derivados - Google Patents

Composição compreendendo ácido caftárico e/ou seus derivados

Info

Publication number
BRPI1007413A2
BRPI1007413A2 BRPI1007413-9A BRPI1007413A BRPI1007413A2 BR PI1007413 A2 BRPI1007413 A2 BR PI1007413A2 BR PI1007413 A BRPI1007413 A BR PI1007413A BR PI1007413 A2 BRPI1007413 A2 BR PI1007413A2
Authority
BR
Brazil
Prior art keywords
derivatives
composition
caffeic acid
caffeic
acid
Prior art date
Application number
BRPI1007413-9A
Other languages
English (en)
Inventor
Rachid Bel-Rhlid
Vanessa Crespy
Thomas Wolfgang Raab
Nicole Page-Zoerkler
René Fumeaux
Maricel Marin-Kuan
Dominique Piguet
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BRPI1007413A2 publication Critical patent/BRPI1007413A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/14Yeasts or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30Dietetic or nutritional methods, e.g. for losing weight
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polymers & Plastics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Virology (AREA)
BRPI1007413-9A 2009-01-27 2010-01-27 Composição compreendendo ácido caftárico e/ou seus derivados BRPI1007413A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09151383A EP2210505A1 (en) 2009-01-27 2009-01-27 Composition comprising caftaric acid and/or derivatives thereof
PCT/EP2010/050929 WO2010086331A2 (en) 2009-01-27 2010-01-27 Composition comprising caftaric acid and/or derivatives thereof

Publications (1)

Publication Number Publication Date
BRPI1007413A2 true BRPI1007413A2 (pt) 2015-08-25

Family

ID=40670988

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1007413-9A BRPI1007413A2 (pt) 2009-01-27 2010-01-27 Composição compreendendo ácido caftárico e/ou seus derivados

Country Status (14)

Country Link
US (1) US20120020926A1 (pt)
EP (2) EP2210505A1 (pt)
JP (1) JP2012515542A (pt)
KR (1) KR20110119724A (pt)
CN (1) CN102333459A (pt)
AR (1) AR075187A1 (pt)
AU (1) AU2010209806A1 (pt)
BR (1) BRPI1007413A2 (pt)
CA (1) CA2750686A1 (pt)
CO (1) CO6390087A2 (pt)
MX (1) MX2011007472A (pt)
RU (1) RU2011135795A (pt)
WO (1) WO2010086331A2 (pt)
ZA (1) ZA201106299B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG186448A1 (en) * 2010-06-30 2013-01-30 Nestec Sa Use of chicoric acid and derivatives for regulating skin pigmentation
RU2012155855A (ru) * 2010-06-30 2014-06-27 Нестек С.А. Применение кафтаровой кислоты и молочнокислых бактерий в биологически активной добавке к пище для регулирования пигментации кожи
SG186804A1 (en) * 2010-06-30 2013-02-28 Nestec Sa Use of caftaric acid and derivatives in food supplement for regulating skin pigmentation
US20140065116A1 (en) * 2011-03-17 2014-03-06 Giovanni Mogna Probiotic bacteria having antioxidant activity and use thereof
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITRM20110477A1 (it) 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
CN102531902A (zh) * 2011-10-20 2012-07-04 沈阳双鼎制药有限公司 一种咖啡酰酒石酸及其制备方法和用途
WO2013190068A1 (en) 2012-06-22 2013-12-27 Nestec S.A. Probiotic and polyphenol against neurodegeneration
ITMI20130793A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
KR20170032815A (ko) * 2015-09-15 2017-03-23 경희대학교 산학협력단 신규 유산균 및 퇴행성 뇌질환 또는 인지기능의 예방, 개선 또는 치료용 조성물
ITUA20162013A1 (it) 2016-03-24 2017-09-24 Probiotical Spa Composizione a base di batteri lattici per il trattamento contemporaneo di infezioni vaginali di origine micotica e batterica.
KR102475667B1 (ko) * 2020-08-07 2022-12-07 김성수 유산균을 포함하는 스트레스 완화, 수면 장애 개선 및 숙면 유지용 조성물
US20240307338A1 (en) * 2021-01-27 2024-09-19 Sichuan Jiuzhang Biological Science And Technology Co., Ltd. Use of pharmaceutical composition containing chlorogenic acid in preparation of medicament for treating pathologic jaundice

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5799193A (en) * 1980-12-08 1982-06-19 Kikkoman Corp Novel enzyme hydrolyzing hydroxy cinnamic ester and its preparation
FR2591073B1 (fr) * 1985-12-10 1988-02-19 Leroux Sarl Chicoree Boisson a base de chicoree et procede de preparation de ladite boisson
WO1997029762A1 (en) * 1996-02-14 1997-08-21 The Procter & Gamble Company Urogenital and intestinal compositions
US20030185811A1 (en) * 2001-02-06 2003-10-02 Steve Teasdale Herbal extract and preparation thereof
FR2827774B1 (fr) * 2001-07-30 2005-06-24 Dolisos Lab Preparations pharmaceutiques et/ou dietetiques contenant un extrait vegetal titre en composes actifs et des micro-organismes probiotiques
JP2003250528A (ja) * 2002-03-06 2003-09-09 Yakult Honsha Co Ltd ビフィドバクテリウム属細菌の生残性改善剤、増殖促進剤、又は、同細菌含有醗酵物の製造方法
US6953574B2 (en) * 2002-06-21 2005-10-11 Technology Commercialization, Inc. Method for producing a fermented hydrolyzed medium containing microorganisms
US20040001898A1 (en) * 2002-06-26 2004-01-01 Armand Malnoe Compositions and methods for detoxification and cancer prevention
WO2004084644A1 (en) * 2003-03-25 2004-10-07 Danmarks Jordbrugsforskning (Danish Institute Of Agricultural Sciences) Methodologies for improving the quality of meat, health status of animals and impact on environment
SE527555C2 (sv) * 2003-04-04 2006-04-11 Probi Ab Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
FR2886817B1 (fr) * 2005-06-10 2007-08-24 Gervais Danone Sa Produit alimentaire enrichi en probiotique et appauvri en acides organiques
AU2006294580B2 (en) * 2005-09-28 2012-07-26 E. & J. Gallo Winery Grape extract, dietary supplement thereof, and processes therefor
FR2904935A1 (fr) * 2006-08-18 2008-02-22 Centre Nat Rech Scient Composition antidiabetique apte a stimuler la secretion d'insuline et destinee au traitement du diabete de type 2 (diabete non insulino-dependant).
FR2906109B1 (fr) * 2006-09-22 2009-09-04 Physcience Soc Par Actions Sim Complement alimentaire pour la prevention et la lutte contre les infections urinaires
PT1911358E (pt) * 2006-10-13 2009-09-23 Gervais Danone Sa Nova composição para melhorar a qualidade da pele e processo para a sua preparação
JP4990297B2 (ja) * 2007-02-01 2012-08-01 株式会社Tkバイオ研究所 ブドウ果皮・種子乳酸菌発酵物及びそれを利用した医薬

Also Published As

Publication number Publication date
KR20110119724A (ko) 2011-11-02
MX2011007472A (es) 2011-08-03
CN102333459A (zh) 2012-01-25
CA2750686A1 (en) 2010-08-05
WO2010086331A3 (en) 2010-09-30
US20120020926A1 (en) 2012-01-26
JP2012515542A (ja) 2012-07-12
AU2010209806A1 (en) 2011-07-28
EP2391230A2 (en) 2011-12-07
CO6390087A2 (es) 2012-02-29
AR075187A1 (es) 2011-03-16
EP2210505A1 (en) 2010-07-28
WO2010086331A2 (en) 2010-08-05
RU2011135795A (ru) 2013-03-10
ZA201106299B (en) 2014-01-29

Similar Documents

Publication Publication Date Title
BRPI1007413A2 (pt) Composição compreendendo ácido caftárico e/ou seus derivados
CY2019013I1 (el) Ενωσεις και συνθεσεις ως αναστολεις πρωτεϊνικης κινασης
IL250259A0 (en) Compositions comprising ursolic acid and derivatives thereof and uses thereof
HRP20160579T1 (hr) Spoj indola i njegova farmaceutska upotreba
BR112013012190A2 (pt) composições adesivas e seus usos
PL2424372T3 (pl) Kompozycje przeciwdrobnoustrojowe i powiązane sposoby zastosowania
PT2448582T (pt) Compostos e composições terapêuticas
BRPI1007194A2 (pt) Composição compreendendo ácido chicórico e/ou derivados do mesmo
BRPI1010079A2 (pt) composição e artigo
PT2473527T (pt) Formulações estáveis de polipéptidos e seus usos
FI20096058A0 (fi) Koostumuksia ja niihin liittyviä menetelmiä ja käyttöjä
BR112013012129A2 (pt) composições de adesivos e seus usos
BRPI0906980A2 (pt) Composição de derivados e maleatados
HRP20170926T1 (hr) Antisens kompozicije i postupci za pripremu i uporabu istih
BR112012031855A2 (pt) composição e artigo
BR112012004448A2 (pt) "compostos e composições como inibidores de proteína cinase"
BR112012002247A2 (pt) composição e artigo
EP2515946A4 (en) NANOCONJUGATES AND COMPOSITIONS OF NANOCONJUGATES
PT2356462T (pt) Composições e métodos anti-cxcr1
BR112012027165A2 (pt) composição e artigo
BR112013002123A2 (pt) composição ácida adesiva para limpeza de sanitários e/ou desodorização
HRP20170936T1 (hr) Alkilamido spojevi i njihova uporaba
BRPI1009446A2 (pt) Composições compreendendo monatina e cálcio
EP2298365A4 (en) MEDICAL COMPOSITION AND MEDICAL KIT
EP2433996A4 (en) LIQUID COMPOSITION AND ENDOSCOPE

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B15K Others concerning applications: alteration of classification

Ipc: A23L 2/52 (2006.01), A23L 33/105 (2016.01), A23L 3